Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Elekta Esprit Radiosurgery Platform Earns FDA Nod - Medical Product Outsourcing
OEM News

Elekta Esprit Radiosurgery Platform Earns FDA Nod

Esprit takes Gamma Knife to the next level with improvements in both the patient and user experience.

Elekta has earned U.S. Food and Drug Administration (FDA) 510(k) clearance for Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform.
 
Leksell Gamma Knife aims to be a gentler alternative to open surgery and conventional radiotherapy. It can target the smallest and most challenging intracranial tumors and lesions with minimal effects on healthy tissue, safeguarding motor, sensory, and neurocognitive function.
 
Verena Schiller, president of Elekta’s Neuroscience Solutions, told the press: “It’s very inspiring to hear how patients treated with Gamma Knife are able to maintain their quality of life and go back to what they love doing after radiosurgery. Thanks to the very low dose delivered outside the target, it’s able to protect surrounding healthy tissue. Esprit takes Gamma Knife to the next level with improvements in both the patient and user experience.”
 
Esprit offers the option of frameless or frame-based workflows as well as remote accessibility and collaboration tools to meet the needs of changing environments.
 
Elekta Esprit is also CE marked.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters